Journals / Meandros Medical And Dental Journal / 2017 / Cilt: 18 - Sayı: 1

Serum Prohepcidin Levels in Children with Thalassemia Major and Intermedia

Talasemi Majör ve İntermedialı Çocuklarda Serum Prohepsidin Düzeyleri

Pages
8–12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Prohepcidin can be an indicator of active erythropoiesis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To determine the role of hepcidin hormone levels in iron accumulation in patients with thalassemia major (TM) and thalassemia intermedia (TI).Materials and Methods: Serum prohepcidin and ferritin levels were determined in 34 patient with TM, 10 patient with TI, who attended the Department of Pediatric Hematology Adnan Menderes University Medical Faculty and the Department of Pediatrics at Aydın Atatürk State Hospital between 1 September 2006 and 30 September 2007 and 40 control patients without infection/inflammation, hepatitis or liver failure.
📊
Key Findings & Data:Marburg, Germany); ferritin was studied with chemiluminescence method (Immulite 2000 DPC).Results: Mean serum ferritin levels in TM, TI and control groups were 2347.97±1724.81 ng/mL (range: 144-8015 ng/mL), 1352.40±918.94 ng/mL (range: 311-3109 ng/mL), and 33.35±12.03 ng/mL (range: 20-69.1 ng/mL), respectively.
💡
Conclusion & Impact:Prohepcidin can be an indicator of active erythropoiesis.
🔬Design:Research Article
📍Scope:2006 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: To determine the role of hepcidin hormone levels in iron accumulation in patients with thalassemia major (TM) and thalassemia intermedia (TI).Materials and Methods: Serum prohepcidin and ferritin levels were determined in 34 patient with TM, 10 patient with TI, who attended the Department of Pediatric Hematology Adnan Menderes University Medical Faculty and the Department of Pediatrics at Aydın Atatürk State Hospital between 1 September 2006 and 30 September 2007 and 40 control patients without infection/inflammation, hepatitis or liver failure. Serum prohepcidin levels were measured using a commercial enzymelinked immunosorbent assay kit (DRG International, Inc. Marburg, Germany); ferritin was studied with chemiluminescence method (Immulite 2000 DPC).Results: Mean serum ferritin levels in TM, TI and control groups were 2347.97±1724.81 ng/mL (range: 144-8015 ng/mL), 1352.40±918.94 ng/mL (range: 311-3109 ng/mL), and 33.35±12.03 ng/mL (range: 20-69.1 ng/mL), respectively. Serum prohepcidin levels in the same groups were 221.78±74.38 ng/mL (range: 7l.14-446.57 ng/mL), 173.31±52.14 ng/mL (range: 100.83-267.69 ng/mL), and 218.20±50.37 ng/mL (range: 116.18-330.43 ng/mL), respectively. There was a statistically significant difference in prohepcidin levels between patients with TI and control group only (p=0.016). No correlation was found between prohepcidin and ferritin levels in all groups (r=-0.023, p=0.839).Conclusion: Low levels of prohepcidin in patients with TI may be related to increased erythropoietic activity. Prohepcidin can be an indicator of active erythropoiesis.

Özet

Amaç: Talasemi majör (TM) ve talasemi intermedialı (Tİ) hastalarda hepsidin hormonunun öncülü olan prohepsidin düzeyleri incelenerek bu hormonun demir birikimindeki rolünü değerlendirmektir. Gereç ve Yöntemler: Adnan Menderes Üniversitesi Tıp Fakültesi, Çocuk Hematoloji Anabilim Dalı ve Aydın Atatürk Devlet Hastanesi'nde 1 Eylül 2006 ve 30 Eylül 2007 tarihleri arasında izlenen ve enfeksiyon, enflamasyon, hepatit ve karaciğer yetmezliği olmayan 34 TM, 10 Tİ'li hastada ve 40 sağlıklı kontrol grubunda serum prohepsidin ve serum ferritin düzeyine bakıldı. Ferritin, Immulite 2000 cihazında kemilüminesans yöntemiyle, prohepsidin DRG International, Inc. Marburg, Germany kiti kullanılarak ELISA yöntemiyle çalışıldı.Bulgular: Ortalama serum ferritin düzeyleri TM, Tİ ve kontrol grubunda sırasıyla 2347,97±1724,81 ng/mL (dağılım, 144-8015 ng/mL), 1352,40±918,94 ng/mL.

🔖

Cite This Article

YILMAZ, C., ARAL, Y. Z., KARUL, A. B., KOZACI, L. D. (2017). Serum Prohepcidin Levels in Children with Thalassemia Major and Intermedia. Meandros Medical And Dental Journal, Cilt: 18 - Sayı: 1, 8–12. https://ajindex.com/articles/282865

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Saliba AN, Harb AR, Taher AT. Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions. Blood Med 2015; 6: 197-209
  2. Gardenghi S, Grady RW, Rivella S. Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in ?-thalassemia. Hematol Oncol Clin North Am 2010; 24: 1089-107
  3. Taher A, Hershko C, Cappellini MD. Iron overload in thalassaemia intermedia: reassessment of iron chelation strategies. Br J Haematol 2009; 147: 634-40
  4. Nemeth E. Hepcidin and ?-thalassemia major. Blood 2013; 122: 3-4
  5. Rishi G, Wallace DF, Subramaniam VN. Hepcidin: regulation of the master iron regulator. Biosci Rep 2015; 35: 1-12
  6. Kim A, Nemeth E. New insights into iron regulation and erythropoiesis. Curr Opin Hematol 2015; 22: 199-205
  7. Musallam KM, Cappellini MD, Wood JC, Taher AT. Iron overload in non-transfusion-dependent thalassemia: a clinical perspective. Blood Rev 2012; 26(Suppl 1): S16-9
  8. Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, Grandchamp B, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 2002; 99: 4596-601
  9. Frazer DM, Inglis HR, Wilkins SJ, Millard KN, Steele TM, McLaren GD, et al. Delayed hepcidin response explains the lag period in iron absorption following a stimulus to increase erythropoiesis. Gut 2004; 53: 1509-15
  10. Uysal Z. Hepsidin ve demir metabolizması
  11. Ulusal hematoloji kongresi kitabı, Ankara, 2007; 9-15
  12. Kulaksiz H, Gehrke SG, Janetzko A, Rost D, Bruckner T, Kallinowski B, et al. Pro-hepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia. Gut 2004; 53: 735-43
  13. Kattamis A, Papassotiriou I, Palaiologou D, Galani FAA, Ladis V, Sakellaropoulos N, et al. The effects of erythropoetic activity and iron burden on hepcidin expression in patients with thalassemia major. Haematologica 2006; 91: 809-12
  14. Adamsky K, Weizer O, Amariglio N, Breda L, Harmelin A, Rivella S, et al. Decreased hepcidin mRNA expression in thalassemic mice. Br J Haematol 2004; 124: 123-4
  15. Franceschi LD, Daraio F, Filippini A, Carturan S, Muchitsch EM, Roetto A, et al. Liver expression of hepcidin and other iron genes in two mouse models of beta thalassemia. Haematolgica 2006; 91: 336-42
  16. Vokurka M, Krijt J, Sulc K, Necas E. Hepcidin mRNA levels in mouse live